
Reflections from DIA and BIO: What Trial Leaders Are Really Saying
I. Introduction: Two Conferences, One Reality This past week at DIA and BIO offered two very different views of the clinical research world. DIA felt
I. Introduction: Two Conferences, One Reality This past week at DIA and BIO offered two very different views of the clinical research world. DIA felt
Making it through the clinical trial start-up process is critical for any study – and takes a lot of effort under normal circumstances. But today,
6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.
If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.
Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?
Getting new treatments approved has never been harder, but recent research reveals that the regulatory agency has also never been faster. So why is it
As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.
Until the recent changes forced upon our industry by COVID-19, clinical research has been anything but digital: instead, relying heavily on in-person interaction, monitoring, and
You’re using the clinical trial site selection checklist you’ve always used, but you’re still struggling with the same delays, site problems, and retraining you see in every trial. Why? It’s time to adjust the way you measure your sites for selection.
Read this excerpt from our eBook.
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea Therapeutics. Akcea is a development and commercialization company focused on
Clinical trial readiness is an essential part of keeping the many people who participate in clinical trials safe while ensuring the trial runs smoothly, remains in compliance, and stays within budget.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
Get new original content and a hand-curated selection of the best life science articles from around the web directly in your inbox. Subscribe to The ArcheMedX Clinical Research Newsletter
See how ArcheMedX applies behavioral science to transform learning and generate actionable insights